UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
AMENDMENT #1
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 1, 2007
XsunX, Inc.
(Exact name of registrant as specified in its charter)
Colorado 000-29621 84-1384159
----------- --------- ----------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
65 Enterprise, Aliso Viejo, California 92656
--------------------------------------------
(Address of principal executive offices and Zip Code)
Registrant's telephone number, including area code (949) 330-8060
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
** This amendment is being filed to file the exhibits listed under Item 9.01.
Item 1.01 Entry into a Material Definitive Agreement.
On November 1, 2007, XsunX signed a $21 million common stock purchase agreement
with Fusion Capital Fund II, LLC, an Illinois limited liability company ("Fusion
Capital"). Upon signing the agreement, XsunX received $1,000,000 from Fusion
Capital as an initial purchase under the $21 million commitment in exchange for
3,333,332 shares of our common stock. Concurrently with entering into the common
stock purchase agreement, we entered into a registration rights agreement with
Fusion Capital. Under the registration rights agreement, we agreed to file a
registration statement related to the transaction with the U.S. Securities &
Exchange Commission ("SEC") covering the shares that have been issued or may be
issued to Fusion Capital under the common stock purchase agreement. After the
SEC has declared effective the registration statement related to the transaction
we have the right over a 25-month period to sell our shares of common stock to
Fusion Capital, from time to time, in amounts up to $1 million per sale,
depending on certain conditions as set forth in the agreement, up to the full
aggregate commitment of $21 million.
The purchase price of the shares related to the $20 million balance of future
funding will be based on the prevailing market prices of the Company's shares at
the time of sales without any fixed discount, and the Company will control the
timing and amount of any sale of shares to Fusion Capital. There are no upper
limits to the price Fusion Capital may pay to purchase our common stock.
However, Fusion Capital shall not be obligated to purchase any shares of our
common stock on any business day that the price of our common stock is below
$0.20. There are no negative covenants, restrictions on future fundings,
penalties or liquidated damages in the agreement. The common stock purchase
agreement may be terminated by us at any time at our discretion without any cost
to us.
In consideration for entering into the $21 million agreement we agreed to issue
to Fusion Capital 3,500,000 shares of our common stock as financing commitment
shares which Fusion Capital has agreed to hold for the term of the common stock
purchase agreement. Additionally, under the stock purchase agreement we granted
Fusion Capital common stock purchase warrants to purchase 1,666,666 shares of
our common stock at $0.50, and 1,666,666 shares of our common stock at $0.75.
The shares underlying the warrant grants do not carry mandatory registration
requirements under the terms of the common stock purchase agreement and
registration rights agreement.
The proceeds received by the Company under the common stock purchase agreement
are expected to be used to build an initial base production system delivering
full size commercial quality solar modules, and initiate the manufacture of the
first of four (4) planned 25 megawatt systems under the Company's planned 100
megawatt thin film solar module production facility. Proceeds may also be used
to lease and prepare manufacturing facilities with the necessary support systems
for the manufacturing line, inventory, staff, and general working capital.
The foregoing description of the common stock purchase agreement, the
registration rights agreement, and the common stock purchase warrants are
qualified in their entirety by reference to the full text of the common stock
purchase agreement, the registration rights agreement, and the common stock
purchase warrants, a copy of each of which is attached hereto as Exhibit 10.1,
10.2 and 10.3, respectively, and each of which is incorporated herein in its
entirety by reference.
Item 3.02 Unregistered Sales of Equity Securities.
The information contained above in Item 1.01 is hereby incorporated by reference
into this Item 3.02.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
10.1 Common Stock Purchase Agreement, dated as of November 1, 2007, by
and between the Company and Fusion Capital Fund II, LLC. (to be
filed by amendment)
10.2 Registration Rights Agreement, dated as of November 1, 2007, by
and between the Company and Fusion Capital Fund II, LLC. (to be
filed by amendment)
10.3 Form of Warrant, dated as of November 1, 2007, by and between the
Company and Fusion Capital Fund II, LLC. (to be filed by
amendment)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
XSUNX, INC.
November 2, 2007 By: /s/ Tom Djokovich
------------------------------
Tom Djokovich, CEO